Catalysts for Aurobindo Pharma Ltd
350 tracked
Apr 20, 2026
approval
PIRFENIDONE — FDA approval
PIRFENIDONE
→
Apr 20, 2026
approval
CANAGLIFLOZIN — FDA approval
CANAGLIFLOZIN
→
Apr 15, 2026
approval
DEXTROMETHORPHAN POLISTIREX — FDA approval
DEXTROMETHORPHAN POLISTIREX
→
Apr 15, 2026
approval
GLYCEROL PHENYLBUTYRATE — FDA approval
GLYCEROL PHENYLBUTYRATE
→
Apr 15, 2026
approval
ALENDRONATE SODIUM — FDA approval
ALENDRONATE SODIUM
→
Apr 9, 2026
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Apr 9, 2026
approval
LAMOTRIGINE — FDA approval
LAMOTRIGINE
→
Apr 6, 2026
approval
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE (DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE) — FDA approval
DAPAGLIFLOZIN
→
Apr 6, 2026
approval
DAPAGLIFLOZIN — FDA approval
DAPAGLIFLOZIN
→
Mar 24, 2026
approval
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) — FDA approval
Aurobindo Pharma Ltd
→
Mar 23, 2026
approval
CINACALCET HYDROCHLORIDE — FDA approval
CINACALCET HYDROCHLORIDE
→
Mar 23, 2026
approval
CEFIXIME — FDA approval
CEFIXIME
→
Mar 18, 2026
approval
VIGABATRIN — FDA approval
VIGABATRIN
→
Mar 18, 2026
approval
CLINDAMYCIN PHOSPHATE — FDA approval
CLEOCIN
→
Mar 18, 2026
approval
VIGABATRIN — FDA approval
VIGABATRIN
→
Mar 18, 2026
approval
MYCOPHENOLATE MOFETIL — FDA approval
MYCOPHENOLATE MOFETIL
→
Mar 13, 2026
approval
CITALOPRAM HYDROBROMIDE — FDA approval
CITALOPRAM HYDROBROMIDE
→
Mar 6, 2026
approval
SIPONIMOD — FDA approval
SIPONIMOD
→
Mar 2, 2026
approval
ONDANSETRON HYDROCHLORIDE — FDA approval
ondansetron hydrochloride CR
→
Feb 24, 2026
approval
FINGOLIMOD HYDROCHLORIDE — FDA approval
FINGOLIMOD HYDROCHLORIDE
→
Feb 18, 2026
approval
ARIPIPRAZOLE — FDA approval
aripiprazole LA
→
Feb 15, 2026
approval
AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN) — FDA approval
amoxicillin
→
Feb 9, 2026
approval
ISOTRETINOIN — FDA approval
ISOTRETINOIN
→
Feb 3, 2026
approval
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jan 26, 2026
approval
BETAMETHASONE DIPROPIONATE — FDA approval
BETAMETHASONE DIPROPIONATE
→
Jan 21, 2026
approval
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) — FDA approval
BISOPROLOL FUMARATE
→
Jan 15, 2026
approval
FLUOXETINE HYDROCHLORIDE — FDA approval
FLUOXETINE HYDROCHLORIDE
→
Jan 15, 2026
approval
FLUOXETINE HYDROCHLORIDE — FDA approval
FLUOXETINE HYDROCHLORIDE
→
Jan 14, 2026
approval
MYCOPHENOLATE SODIUM — FDA approval
mycophenolate sodium DR
→
Jan 14, 2026
approval
MYCOPHENOLATE MOFETIL — FDA approval
MYCOPHENOLATE MOFETIL
→